 | • レポートコード：MRC2-11QY04304 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は肺炎検査のグローバル市場について調査・分析したレポートです。種類別（消耗品、分析装置）市場規模、用途別（病院、診療所、医療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別肺炎検査の競争状況、市場シェア ・世界の肺炎検査市場：種類別市場規模 2015年-2020年（消耗品、分析装置） ・世界の肺炎検査市場：種類別市場規模予測 2021年-2026年（消耗品、分析装置） ・世界の肺炎検査市場：用途別市場規模 2015年-2020年（病院、診療所、医療センター、その他） ・世界の肺炎検査市場：用途別市場規模予測 2021年-2026年（病院、診療所、医療センター、その他） ・北米の肺炎検査市場分析：米国、カナダ ・ヨーロッパの肺炎検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの肺炎検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の肺炎検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの肺炎検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Molecular、Fast-track diagnostics、Becton, Dickenson and Company (BD)、Roche Molecular Diagnostics、Thermo Fisher Scientific、AdvanDx、Abbott、Beckman Coulter、Bio-Rad、Cepheid、Concile、Diamedix、DiaSorin、Eiken Chemical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Pneumonia is a complicated infection of the lower respiratory tract. It may start on or after an upper respiratory tract infection.
The rising popularity of point-of-care (POC) testing as one of the primary growth factors for this market.
Market Analysis and Insights: Global Pneumonia Testing Market
The global Pneumonia Testing market size is projected to reach US$ 959.8 million by 2026, from US$ 889.1 million in 2020, at a CAGR of 7.4%% during 2021-2026.
Global Pneumonia Testing Scope and Market Size
Pneumonia Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pneumonia Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Molecular
Fast-track diagnostics
Becton, Dickenson and Company (BD)
Roche Molecular Diagnostics
Thermo Fisher Scientific
AdvanDx
Abbott
Beckman Coulter
Bio-Rad
Cepheid
Concile
Diamedix
DiaSorin
Eiken Chemical
Market segment by Type, the product can be split into
Consumables
Analyzers
Market segment by Application, split into
Hospital
Clinic
Medical Center
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pneumonia Testing Revenue
1.4 Market by Type
1.4.1 Global Pneumonia Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Consumables
1.4.3 Analyzers
1.5 Market by Application
1.5.1 Global Pneumonia Testing Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Medical Center
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pneumonia Testing Market Perspective (2015-2026)
2.2 Global Pneumonia Testing Growth Trends by Regions
2.2.1 Pneumonia Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pneumonia Testing Historic Market Share by Regions (2015-2020)
2.2.3 Pneumonia Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pneumonia Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Pneumonia Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pneumonia Testing Players by Market Size
3.1.1 Global Top Pneumonia Testing Players by Revenue (2015-2020)
3.1.2 Global Pneumonia Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Pneumonia Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pneumonia Testing Market Concentration Ratio
3.2.1 Global Pneumonia Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pneumonia Testing Revenue in 2019
3.3 Pneumonia Testing Key Players Head office and Area Served
3.4 Key Players Pneumonia Testing Product Solution and Service
3.5 Date of Enter into Pneumonia Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pneumonia Testing Historic Market Size by Type (2015-2020)
4.2 Global Pneumonia Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pneumonia Testing Market Size by Application (2015-2020)
5.2 Global Pneumonia Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pneumonia Testing Market Size (2015-2020)
6.2 Pneumonia Testing Key Players in North America (2019-2020)
6.3 North America Pneumonia Testing Market Size by Type (2015-2020)
6.4 North America Pneumonia Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pneumonia Testing Market Size (2015-2020)
7.2 Pneumonia Testing Key Players in Europe (2019-2020)
7.3 Europe Pneumonia Testing Market Size by Type (2015-2020)
7.4 Europe Pneumonia Testing Market Size by Application (2015-2020)
8 China
8.1 China Pneumonia Testing Market Size (2015-2020)
8.2 Pneumonia Testing Key Players in China (2019-2020)
8.3 China Pneumonia Testing Market Size by Type (2015-2020)
8.4 China Pneumonia Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pneumonia Testing Market Size (2015-2020)
9.2 Pneumonia Testing Key Players in Japan (2019-2020)
9.3 Japan Pneumonia Testing Market Size by Type (2015-2020)
9.4 Japan Pneumonia Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pneumonia Testing Market Size (2015-2020)
10.2 Pneumonia Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pneumonia Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Pneumonia Testing Market Size by Application (2015-2020)
11 India
11.1 India Pneumonia Testing Market Size (2015-2020)
11.2 Pneumonia Testing Key Players in India (2019-2020)
11.3 India Pneumonia Testing Market Size by Type (2015-2020)
11.4 India Pneumonia Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pneumonia Testing Market Size (2015-2020)
12.2 Pneumonia Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Pneumonia Testing Market Size by Type (2015-2020)
12.4 Central & South America Pneumonia Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Molecular
13.1.1 Abbott Molecular Company Details
13.1.2 Abbott Molecular Business Overview
13.1.3 Abbott Molecular Pneumonia Testing Introduction
13.1.4 Abbott Molecular Revenue in Pneumonia Testing Business (2015-2020))
13.1.5 Abbott Molecular Recent Development
13.2 Fast-track diagnostics
13.2.1 Fast-track diagnostics Company Details
13.2.2 Fast-track diagnostics Business Overview
13.2.3 Fast-track diagnostics Pneumonia Testing Introduction
13.2.4 Fast-track diagnostics Revenue in Pneumonia Testing Business (2015-2020)
13.2.5 Fast-track diagnostics Recent Development
13.3 Becton, Dickenson and Company (BD)
13.3.1 Becton, Dickenson and Company (BD) Company Details
13.3.2 Becton, Dickenson and Company (BD) Business Overview
13.3.3 Becton, Dickenson and Company (BD) Pneumonia Testing Introduction
13.3.4 Becton, Dickenson and Company (BD) Revenue in Pneumonia Testing Business (2015-2020)
13.3.5 Becton, Dickenson and Company (BD) Recent Development
13.4 Roche Molecular Diagnostics
13.4.1 Roche Molecular Diagnostics Company Details
13.4.2 Roche Molecular Diagnostics Business Overview
13.4.3 Roche Molecular Diagnostics Pneumonia Testing Introduction
13.4.4 Roche Molecular Diagnostics Revenue in Pneumonia Testing Business (2015-2020)
13.4.5 Roche Molecular Diagnostics Recent Development
13.5 Thermo Fisher Scientific
13.5.1 Thermo Fisher Scientific Company Details
13.5.2 Thermo Fisher Scientific Business Overview
13.5.3 Thermo Fisher Scientific Pneumonia Testing Introduction
13.5.4 Thermo Fisher Scientific Revenue in Pneumonia Testing Business (2015-2020)
13.5.5 Thermo Fisher Scientific Recent Development
13.6 AdvanDx
13.6.1 AdvanDx Company Details
13.6.2 AdvanDx Business Overview
13.6.3 AdvanDx Pneumonia Testing Introduction
13.6.4 AdvanDx Revenue in Pneumonia Testing Business (2015-2020)
13.6.5 AdvanDx Recent Development
13.7 Abbott
13.7.1 Abbott Company Details
13.7.2 Abbott Business Overview
13.7.3 Abbott Pneumonia Testing Introduction
13.7.4 Abbott Revenue in Pneumonia Testing Business (2015-2020)
13.7.5 Abbott Recent Development
13.8 Beckman Coulter
13.8.1 Beckman Coulter Company Details
13.8.2 Beckman Coulter Business Overview
13.8.3 Beckman Coulter Pneumonia Testing Introduction
13.8.4 Beckman Coulter Revenue in Pneumonia Testing Business (2015-2020)
13.8.5 Beckman Coulter Recent Development
13.9 Bio-Rad
13.9.1 Bio-Rad Company Details
13.9.2 Bio-Rad Business Overview
13.9.3 Bio-Rad Pneumonia Testing Introduction
13.9.4 Bio-Rad Revenue in Pneumonia Testing Business (2015-2020)
13.9.5 Bio-Rad Recent Development
13.10 Cepheid
13.10.1 Cepheid Company Details
13.10.2 Cepheid Business Overview
13.10.3 Cepheid Pneumonia Testing Introduction
13.10.4 Cepheid Revenue in Pneumonia Testing Business (2015-2020)
13.10.5 Cepheid Recent Development
13.11 Concile
10.11.1 Concile Company Details
10.11.2 Concile Business Overview
10.11.3 Concile Pneumonia Testing Introduction
10.11.4 Concile Revenue in Pneumonia Testing Business (2015-2020)
10.11.5 Concile Recent Development
13.12 Diamedix
10.12.1 Diamedix Company Details
10.12.2 Diamedix Business Overview
10.12.3 Diamedix Pneumonia Testing Introduction
10.12.4 Diamedix Revenue in Pneumonia Testing Business (2015-2020)
10.12.5 Diamedix Recent Development
13.13 DiaSorin
10.13.1 DiaSorin Company Details
10.13.2 DiaSorin Business Overview
10.13.3 DiaSorin Pneumonia Testing Introduction
10.13.4 DiaSorin Revenue in Pneumonia Testing Business (2015-2020)
10.13.5 DiaSorin Recent Development
13.14 Eiken Chemical
10.14.1 Eiken Chemical Company Details
10.14.2 Eiken Chemical Business Overview
10.14.3 Eiken Chemical Pneumonia Testing Introduction
10.14.4 Eiken Chemical Revenue in Pneumonia Testing Business (2015-2020)
10.14.5 Eiken Chemical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Pneumonia Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Pneumonia Testing Revenue
Table 3. Ranking of Global Top Pneumonia Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pneumonia Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Consumables
Table 6. Key Players of Analyzers
Table 7. Global Pneumonia Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Pneumonia Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Pneumonia Testing Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Pneumonia Testing Market Share by Regions (2015-2020)
Table 11. Global Pneumonia Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Pneumonia Testing Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Pneumonia Testing Market Growth Strategy
Table 17. Main Points Interviewed from Key Pneumonia Testing Players
Table 18. Global Pneumonia Testing Revenue by Players (2015-2020) (Million US$)
Table 19. Global Pneumonia Testing Market Share by Players (2015-2020)
Table 20. Global Top Pneumonia Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Testing as of 2019)
Table 21. Global Pneumonia Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pneumonia Testing Product Solution and Service
Table 24. Date of Enter into Pneumonia Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pneumonia Testing Market Size by Type (2015-2020) (Million US$)
Table 27. Global Pneumonia Testing Market Size Share by Type (2015-2020)
Table 28. Global Pneumonia Testing Revenue Market Share by Type (2021-2026)
Table 29. Global Pneumonia Testing Market Size Share by Application (2015-2020)
Table 30. Global Pneumonia Testing Market Size by Application (2015-2020) (Million US$)
Table 31. Global Pneumonia Testing Market Size Share by Application (2021-2026)
Table 32. North America Key Players Pneumonia Testing Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Pneumonia Testing Market Share (2019-2020)
Table 34. North America Pneumonia Testing Market Size by Type (2015-2020) (Million US$)
Table 35. North America Pneumonia Testing Market Share by Type (2015-2020)
Table 36. North America Pneumonia Testing Market Size by Application (2015-2020) (Million US$)
Table 37. North America Pneumonia Testing Market Share by Application (2015-2020)
Table 38. Europe Key Players Pneumonia Testing Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Pneumonia Testing Market Share (2019-2020)
Table 40. Europe Pneumonia Testing Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Pneumonia Testing Market Share by Type (2015-2020)
Table 42. Europe Pneumonia Testing Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Pneumonia Testing Market Share by Application (2015-2020)
Table 44. China Key Players Pneumonia Testing Revenue (2019-2020) (Million US$)
Table 45. China Key Players Pneumonia Testing Market Share (2019-2020)
Table 46. China Pneumonia Testing Market Size by Type (2015-2020) (Million US$)
Table 47. China Pneumonia Testing Market Share by Type (2015-2020)
Table 48. China Pneumonia Testing Market Size by Application (2015-2020) (Million US$)
Table 49. China Pneumonia Testing Market Share by Application (2015-2020)
Table 50. Japan Key Players Pneumonia Testing Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Pneumonia Testing Market Share (2019-2020)
Table 52. Japan Pneumonia Testing Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Pneumonia Testing Market Share by Type (2015-2020)
Table 54. Japan Pneumonia Testing Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Pneumonia Testing Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Pneumonia Testing Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Pneumonia Testing Market Share (2019-2020)
Table 58. Southeast Asia Pneumonia Testing Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Pneumonia Testing Market Share by Type (2015-2020)
Table 60. Southeast Asia Pneumonia Testing Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Pneumonia Testing Market Share by Application (2015-2020)
Table 62. India Key Players Pneumonia Testing Revenue (2019-2020) (Million US$)
Table 63. India Key Players Pneumonia Testing Market Share (2019-2020)
Table 64. India Pneumonia Testing Market Size by Type (2015-2020) (Million US$)
Table 65. India Pneumonia Testing Market Share by Type (2015-2020)
Table 66. India Pneumonia Testing Market Size by Application (2015-2020) (Million US$)
Table 67. India Pneumonia Testing Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Pneumonia Testing Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Pneumonia Testing Market Share (2019-2020)
Table 70. Central & South America Pneumonia Testing Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Pneumonia Testing Market Share by Type (2015-2020)
Table 72. Central & South America Pneumonia Testing Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Pneumonia Testing Market Share by Application (2015-2020)
Table 74. Abbott Molecular Company Details
Table 75. Abbott Molecular Business Overview
Table 76. Abbott Molecular Product
Table 77. Abbott Molecular Revenue in Pneumonia Testing Business (2015-2020) (Million US$)
Table 78. Abbott Molecular Recent Development
Table 79. Fast-track diagnostics Company Details
Table 80. Fast-track diagnostics Business Overview
Table 81. Fast-track diagnostics Product
Table 82. Fast-track diagnostics Revenue in Pneumonia Testing Business (2015-2020) (Million US$)
Table 83. Fast-track diagnostics Recent Development
Table 84. Becton, Dickenson and Company (BD) Company Details
Table 85. Becton, Dickenson and Company (BD) Business Overview
Table 86. Becton, Dickenson and Company (BD) Product
Table 87. Becton, Dickenson and Company (BD) Revenue in Pneumonia Testing Business (2015-2020) (Million US$)
Table 88. Becton, Dickenson and Company (BD) Recent Development
Table 89. Roche Molecular Diagnostics Company Details
Table 90. Roche Molecular Diagnostics Business Overview
Table 91. Roche Molecular Diagnostics Product
Table 92. Roche Molecular Diagnostics Revenue in Pneumonia Testing Business (2015-2020) (Million US$)
Table 93. Roche Molecular Diagnostics Recent Development
Table 94. Thermo Fisher Scientific Company Details
Table 95. Thermo Fisher Scientific Business Overview
Table 96. Thermo Fisher Scientific Product
Table 97. Thermo Fisher Scientific Revenue in Pneumonia Testing Business (2015-2020) (Million US$)
Table 98. Thermo Fisher Scientific Recent Development
Table 99. AdvanDx Company Details
Table 100. AdvanDx Business Overview
Table 101. AdvanDx Product
Table 102. AdvanDx Revenue in Pneumonia Testing Business (2015-2020) (Million US$)
Table 103. AdvanDx Recent Development
Table 104. Abbott Company Details
Table 105. Abbott Business Overview
Table 106. Abbott Product
Table 107. Abbott Revenue in Pneumonia Testing Business (2015-2020) (Million US$)
Table 108. Abbott Recent Development
Table 109. Beckman Coulter Business Overview
Table 110. Beckman Coulter Product
Table 111. Beckman Coulter Company Details
Table 112. Beckman Coulter Revenue in Pneumonia Testing Business (2015-2020) (Million US$)
Table 113. Beckman Coulter Recent Development
Table 114. Bio-Rad Company Details
Table 115. Bio-Rad Business Overview
Table 116. Bio-Rad Product
Table 117. Bio-Rad Revenue in Pneumonia Testing Business (2015-2020) (Million US$)
Table 118. Bio-Rad Recent Development
Table 119. Cepheid Company Details
Table 120. Cepheid Business Overview
Table 121. Cepheid Product
Table 122. Cepheid Revenue in Pneumonia Testing Business (2015-2020) (Million US$)
Table 123. Cepheid Recent Development
Table 124. Concile Company Details
Table 125. Concile Business Overview
Table 126. Concile Product
Table 127. Concile Revenue in Pneumonia Testing Business (2015-2020) (Million US$)
Table 128. Concile Recent Development
Table 129. Diamedix Company Details
Table 130. Diamedix Business Overview
Table 131. Diamedix Product
Table 132. Diamedix Revenue in Pneumonia Testing Business (2015-2020) (Million US$)
Table 133. Diamedix Recent Development
Table 134. DiaSorin Company Details
Table 135. DiaSorin Business Overview
Table 136. DiaSorin Product
Table 137. DiaSorin Revenue in Pneumonia Testing Business (2015-2020) (Million US$)
Table 138. DiaSorin Recent Development
Table 139. Eiken Chemical Company Details
Table 140. Eiken Chemical Business Overview
Table 141. Eiken Chemical Product
Table 142. Eiken Chemical Revenue in Pneumonia Testing Business (2015-2020) (Million US$)
Table 143. Eiken Chemical Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pneumonia Testing Market Share by Type: 2020 VS 2026
Figure 2. Consumables Features
Figure 3. Analyzers Features
Figure 4. Global Pneumonia Testing Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Medical Center Case Studies
Figure 8. Other Case Studies
Figure 9. Pneumonia Testing Report Years Considered
Figure 10. Global Pneumonia Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Pneumonia Testing Market Share by Regions: 2020 VS 2026
Figure 12. Global Pneumonia Testing Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Pneumonia Testing Market Share by Players in 2019
Figure 15. Global Top Pneumonia Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Testing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Pneumonia Testing Revenue in 2019
Figure 17. North America Pneumonia Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Pneumonia Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Pneumonia Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Pneumonia Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Pneumonia Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Pneumonia Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Pneumonia Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
院内肺炎予防の世界市場（～2026年） HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcar…- 肺炎治療薬の世界市場（～2026年） Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection. The emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years. Market Analysis and…
- 肺炎の世界市場（～2026年） Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affec…
- 細菌性肺炎治療薬の世界市場（～2026年） Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affec…
- 人工呼吸器関連肺炎（VAP）の世界市場（～2026年） Market Analysis and Insights: Global Ventilator Associated Pneumonia (VAP) Market The global Ventilator Associated Pneumonia (VAP) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ventilator Associated Pneumonia (VAP) S…